Israeli Soldiers Open Fire on Palestinian Protesters
Two teenagers were hospitalized Monday after Israeli soldiers tried to end a Palestinian demonstration near Bethlehem by firing on the crowd, The New York Times reports.
Two teenagers were hospitalized Monday after Israeli soldiers tried to end a Palestinian demonstration near Bethlehem by firing on the crowd, The New York Times reports.
The West Bank has been in a tumult since a Palestinian prisoner named Arafat Jaradat died in Israeli custody over the weekend. Israeli authorities conducted an autopsy but have yet to determine or confirm the cause of death.
The New York Times:
But more serious clashes broke out near Rachel’s Tomb on Monday afternoon and evening. An Israeli military official who spoke on the condition of anonymity said that soldiers fired .22-caliber rounds at Palestinians who were throwing improvised grenades at worshipers near the tomb, which is next to the Aida refugee camp just outside Bethlehem.
A doctor at Beit Jala Hospital who spoke on the condition that he not be identified said a 13-year-old had been shot in a lung during that protest and was in the intensive care unit Monday night after undergoing surgery. Hours later, a 19-year-old Palestinian was shot as the demonstration raged on, the doctor said.
“He is in a dangerous situation,” the doctor said of the second patient. “Doctors are trying to save his life.”
— Posted by Peter Z. Scheer.
WAIT BEFORE YOU GO...This year, the ground feels uncertain — facts are buried and those in power are working to keep them hidden. Now more than ever, independent journalism must go beneath the surface.
At Truthdig, we don’t just report what's happening — we investigate how and why. We follow the threads others leave behind and uncover the forces shaping our future.
Your tax-deductible donation fuels journalism that asks harder questions and digs where others won’t.
Don’t settle for surface-level coverage.
Unearth what matters. Help dig deeper.
Donate now.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.